Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Psychoneuroendocrinology. 2014 Jan 22;42:118–123. doi: 10.1016/j.psyneuen.2014.01.006

Appendix Table 1.

Demographic and Health Information as a Total Sample and by IGF-1 Level (N = 94)

Total
IGF-1 Level
Low (≤ 75 ng/ml)
N = 48
High (> 75 ng/ml)
N = 46
t or χ2 test or F test (p value) df


log IGF-1, Mean (SD) −0.32 (0.35) −0.59 (0.23) −0.03 (0.20) −12.43(< .001) 92
Age, Mean (SD) 60.68 (8.42) 62.36 (8.46) 58.91 (8.09) 2.02 (.046) 92
Male, n (%) 39 (41.5%) 22 (45.8%) 17 (37.0%) 0.83 (.41)
Years of education, Mean (SD) 15.03 (3.39) 14.48 (3.51) 15.61 (3.19) −1.63 (.11) 92
BMI, Mean (SD) 26.80 (4.55) 26.70 (5.14) 26.92 (3.89) −0.23 (.82) 92
Use of ERT, n (%) 4 (4.3%) 3 (6.3%) 1 (2.2%) 0.33 (.62) 1
Use of anti-hypertensive, n (%) 18 (19.1%) 11 (22.9%) 7 (15.2%) 0.34 (.44) 1
Sleep quality, Mean (SD) § 4.87 (2.90) 4.57 (2.77) 5.18 (3.03) −1.00 (.32) 90
GDS 1.05 (0.87) 0.98 (0.92) 1.12 (0.12) −0.79 (.43) 92
AVLT total learning, Mean (SD) 44.22 (8.62) 8.86 (1.28) 8.37 (1.23) 0.20 (.66) a 91, 1
AVLT immediate recall, Mean (SD) 8.83 (2.82) 8.46 (3.06) 9.22 (2.52) 1.17 (.28) a 91, 1
AVLT delayed recall, Mean (SD) 8.26 (3.06) 7.67 (3.37) 8.87 (2.59) 3.71 (.057) a 91, 1
AVLT recognition, Mean (SD) 9.48 (4.13) 8.63 (4.73) 10.37 (3.21) 3.71 (.057) a 91, 1

Note.

§

two persons’ data were missing.

GDS was recoded as ln(GDS raw score +1).

a

controlled for age.